NLP9 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
NLP9 antibody; At3g59580 antibody; T16L24.130Protein NLP9 antibody; AtNLP9 antibody; NIN-like protein 9 antibody; Nodule inception protein-like protein 8 antibody
Target Names
NLP9
Uniprot No.

Target Background

Function
This antibody targets a protein that is likely a transcription factor.
Database Links

KEGG: ath:AT3G59580

STRING: 3702.AT3G59580.1

UniGene: At.34613

Subcellular Location
Nucleus.

Q&A

What is NLP9 and why is it important in plant biology?

NLP9 (NIN-LIKE PROTEIN 9) is a plant regulator belonging to the RWP-RK transcription factor family in Arabidopsis thaliana . The NIN-like protein family plays crucial roles in plant nitrogen sensing, signaling, and metabolic regulation. Understanding NLP9 function is essential for elucidating nitrogen use efficiency in plants, which has significant implications for agricultural productivity and sustainability. The protein is encoded by gene AT3G59580 with UniProt identifier Q9M1B0 .

What research applications are suitable for NLP9 antibodies?

NLP9 antibodies are primarily used in plant biology research for:

  • Immunohistochemistry to localize NLP9 protein in plant tissues

  • Western blot analysis to detect and quantify NLP9 expression

  • Chromatin immunoprecipitation (ChIP) to study NLP9 binding to DNA

  • Co-immunoprecipitation to identify protein-protein interactions

  • Immunofluorescence microscopy to visualize subcellular localization

These applications help researchers understand NLP9's role in nitrogen response pathways, plant development, and stress responses.

How do NLP9 antibodies compare to other tools for studying NIN-like proteins?

While genetic approaches (mutants, RNAi, CRISPR) reveal functional roles, antibodies provide unique advantages for studying native protein:

Research ApproachAdvantagesLimitations
NLP9 AntibodiesDetect endogenous protein levels, Visualize subcellular localization, Study protein modificationsPotential cross-reactivity, Variable specificity
TranscriptomicsGenome-wide expression analysis, Temporal regulation insightsDoes not reflect protein levels or activity
Transgenic reportersIn vivo visualization, Temporal trackingMay not reflect endogenous regulation
Mutant analysisDirect functional insightsPotential functional redundancy among NLPs

What controls should be included when using NLP9 antibodies in immunodetection experiments?

Proper experimental controls are critical for reliable results:

  • Positive controls:

    • Recombinant NLP9 protein

    • Arabidopsis tissues known to express high NLP9 levels (e.g., nitrogen-stimulated roots)

  • Negative controls:

    • NLP9 knockout/knockdown plant tissues

    • Pre-immune serum or isotype control antibodies

    • Peptide competition assay (pre-incubating antibody with immunizing peptide)

  • Specificity controls:

    • Testing for cross-reactivity with other NLP family members, particularly NLP6 which may share structural similarities

This comprehensive control strategy helps validate antibody specificity and experimental reliability.

How should researchers optimize immunohistochemistry protocols for NLP9 detection in plant tissues?

Optimization strategies include:

  • Fixation method selection:

    • Compare paraformaldehyde, glutaraldehyde, and methanol fixation

    • Determine optimal fixation duration (typically 10-30 minutes)

  • Antigen retrieval:

    • Test heat-induced (citrate buffer, pH 6.0) vs. enzymatic methods

    • Optimize retrieval conditions based on tissue type

  • Blocking optimization:

    • Compare BSA, normal serum, or commercial blocking reagents

    • Test different blocking durations (1-4 hours)

  • Antibody dilution optimization:

    • Create dilution series (1:100 to 1:5000) to determine optimal signal-to-noise ratio

    • Test both overnight 4°C and room temperature incubation protocols

  • Detection system selection:

    • Compare fluorescent vs. chromogenic detection methods

    • Optimize signal amplification if needed

What are the potential sources of false-positive and false-negative results when using NLP9 antibodies?

Understanding these potential pitfalls is crucial for reliable interpretation:

Error TypePossible CausesMitigation Strategies
False PositivesCross-reactivity with related NLP proteins (NLP2-7), Non-specific binding due to high antibody concentration, Endogenous peroxidase activityUse validated antibodies with known specificity, Optimize antibody dilutions, Include hydrogen peroxide quenching step
False NegativesEpitope masking due to protein modifications, Protein degradation during sample preparation, Insufficient antigen retrievalTest multiple antibodies targeting different epitopes, Use protease inhibitors during extraction, Optimize antigen retrieval protocols

How can NLP9 antibodies be used to study post-translational modifications of NLP proteins?

Post-translational modifications (PTMs) significantly impact NLP function. Strategies include:

  • Phosphorylation analysis:

    • Use phospho-specific NLP9 antibodies if available

    • Combine general NLP9 antibodies with phosphatase treatments

    • Use 2D gel electrophoresis followed by Western blotting to separate phosphorylated forms

  • Ubiquitination detection:

    • Perform immunoprecipitation with NLP9 antibody followed by ubiquitin blotting

    • Use proteasome inhibitors to stabilize ubiquitinated forms

  • Subcellular localization shifts:

    • Track nuclear-cytoplasmic shuttling in response to nitrogen signaling using fractionation and immunoblotting

PTM mapping helps elucidate regulatory mechanisms controlling NLP9 activity in nitrogen response pathways.

What approaches can resolve conflicting data between antibody-based NLP9 detection and transcript analysis?

When protein and transcript data disagree, consider these methodological approaches:

  • Temporal resolution analysis:

    • Perform time-course experiments to capture potential delays between transcription and translation

    • Compare half-lives of mRNA vs. protein

  • Post-transcriptional regulation assessment:

    • Examine microRNA targeting of NLP9 transcripts

    • Analyze translation efficiency via polysome profiling

  • Protein stability analysis:

    • Use cycloheximide chase assays with NLP9 antibody detection

    • Compare protein degradation rates under different conditions

  • Technical validation:

    • Confirm antibody specificity using knockout/knockdown lines

    • Validate transcript detection with multiple primer sets or approaches

These strategies help reconcile apparently contradictory data between transcript and protein levels.

What are the optimal sample preparation methods for NLP9 detection in plant tissues?

Sample preparation greatly impacts antibody detection success:

  • Protein extraction buffers:

    Buffer ComponentRecommended ConcentrationPurpose
    Tris-HCl (pH 7.5)50 mMMaintains neutral pH
    NaCl150 mMProvides ionic strength
    EDTA5 mMChelates metal ions, inhibits metalloproteases
    Triton X-100 or NP-400.1-1%Solubilizes membranes
    Protease inhibitorsAs recommendedPrevents protein degradation
    Phosphatase inhibitorsAs recommendedPreserves phosphorylation status
    DTT or β-mercaptoethanol1-5 mMReduces disulfide bonds
  • Tissue-specific considerations:

    • Root tissues: Rinse thoroughly to remove soil contaminants

    • Leaf tissues: Remove mid-veins for more homogeneous samples

    • Nitrogen-treated samples: Process rapidly to capture transient modifications

  • Homogenization methods:

    • Liquid nitrogen grinding for preserved tissues

    • Mechanical disruption (polytron) for fresh tissues

    • Avoid excessive heat generation during processing

How can researchers validate NLP9 antibody specificity for plant research applications?

Comprehensive validation includes:

  • Genetic validation:

    • Compare detection in wild-type vs. NLP9 knockout/knockdown lines

    • Test in NLP9 overexpression lines for increased signal

  • Biochemical validation:

    • Peptide competition assays

    • Western blot analysis for single band of expected molecular weight

    • Mass spectrometry confirmation of immunoprecipitated proteins

  • Cross-reactivity assessment:

    • Test against recombinant proteins of related NLP family members

    • Evaluate specificity across plant species if conducting comparative studies

  • Application-specific validation:

    • For ChIP applications, verify enrichment at known NLP9 binding sites

    • For immunolocalization, confirm subcellular pattern matches known localization

What approaches can enhance signal detection when NLP9 expression is low?

For low-abundance detection, consider:

  • Signal amplification methods:

    • Tyramide signal amplification (TSA) for immunohistochemistry

    • Enhanced chemiluminescence (ECL) substrates for Western blot

    • Biotin-streptavidin amplification systems

  • Sample enrichment strategies:

    • Nuclear extraction for transcription factors

    • Immunoprecipitation before detection

    • Nitrogen treatment to upregulate expression

  • Technical optimizations:

    • Extended antibody incubation times (overnight at 4°C)

    • Increased antibody concentration (with careful validation)

    • Optimized blocking to reduce background

How should researchers interpret differences in NLP9 detection between different experimental techniques?

Technique-specific considerations include:

TechniquePotential LimitationsInterpretation Guidelines
Western BlotDenatured proteins may alter epitope exposureCompare with native protein detection methods
ImmunohistochemistryFixation can mask epitopesTest multiple fixation protocols
ImmunoprecipitationAntibody might disrupt protein interactionsUse multiple antibodies targeting different regions
ChIPCrosslinking efficiency affects detectionInclude controls for antibody accessibility

What are the current controversies or knowledge gaps regarding NLP9 function that antibody-based approaches could help resolve?

Key research frontiers include:

  • NLP family member redundancy:

    • How specific antibodies can help distinguish functions between NLP9 and other family members

    • Techniques for studying protein-specific interactions within the NLP family

  • Regulatory mechanisms:

    • Detecting specific phosphorylation events controlling nuclear localization

    • Identifying protein-protein interactions unique to NLP9 vs. other NLPs

  • Species-specific variations:

    • Cross-species reactivity considerations for evolutionary studies

    • Epitope conservation analysis for comparative studies

How can researchers effectively combine NLP9 antibody techniques with other methodologies for comprehensive protein function analysis?

Integrated research strategies include:

  • Multi-omics integration:

    • Correlate antibody-detected protein levels with transcriptomics data

    • Combine with metabolomics to link NLP9 activity to nitrogen metabolism

  • Functional validation approaches:

    • Use antibodies to confirm protein-protein interactions identified in yeast two-hybrid screens

    • Validate ChIP-seq results with targeted ChIP-qPCR using NLP9 antibodies

  • Spatiotemporal analysis:

    • Combine reporter lines with antibody staining to validate expression patterns

    • Use inducible systems with antibody detection to establish direct consequences of NLP9 activation

These integrated approaches maximize the value of NLP9 antibodies in comprehensive research programs.

What are common troubleshooting strategies when NLP9 antibody experiments fail to produce expected results?

Systematic troubleshooting approach:

  • No signal detected:

    • Verify NLP9 expression in sample (RT-PCR)

    • Test antibody functionality with positive controls

    • Optimize protein extraction method

    • Try alternative detection systems

  • Multiple bands in Western blot:

    • Adjust stringency of washing conditions

    • Optimize blocking conditions

    • Verify sample integrity (add protease inhibitors)

    • Consider possible isoforms or post-translational modifications

  • High background in immunostaining:

    • Increase blocking duration/concentration

    • Optimize antibody dilution

    • Extend washing steps

    • Use more specific secondary antibodies

Each troubleshooting strategy should be systematically tested and documented to identify the source of experimental issues.

How are advances in antibody engineering and production impacting NLP9 research?

Recent technological developments include:

  • Recombinant antibody technologies:

    • Single-chain variable fragments (scFvs) for improved tissue penetration

    • Nanobodies derived from camelid antibodies for accessing restricted epitopes

  • Multiplexing capabilities:

    • Antibodies with distinct fluorophores for co-localization studies

    • Proximity ligation assays for detecting protein interactions in situ

  • Enhanced specificity approaches:

    • CRISPR-generated knockout validation systems

    • Epitope-tagged endogenous NLP9 for antibody validation

These advances are expanding the toolkit available for studying NLP9 and related plant transcription factors with unprecedented precision.

What emerging applications of NLP9 antibodies are being developed for agricultural research?

Frontier applications include:

  • Nitrogen use efficiency biomarkers:

    • Using NLP9 detection to screen for improved nitrogen response in crop varieties

    • Developing antibody-based field-deployable diagnostics for nitrogen status

  • Stress response monitoring:

    • Tracking NLP9 modifications under environmental stress conditions

    • Correlating NLP9 activity with drought or salinity tolerance

  • Crop improvement applications:

    • Screening germplasm collections for NLP9 variants with enhanced activity

    • Monitoring NLP9 responses to biostimulants or agricultural amendments

These applications bridge fundamental research with practical agricultural applications.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.